These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24549714)

  • 1. A GLP-1 receptor agonist conjugated to an albumin-binding domain for extended half-life.
    Lindgren J; Refai E; Zaitsev SV; Abrahmsén L; Berggren PO; Karlström AE
    Biopolymers; 2014 May; 102(3):252-9. PubMed ID: 24549714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin-binding domain extends half-life of glucagon-like peptide-1.
    Tan H; Su W; Zhang W; Zhang J; Sattler M; Zou P
    Eur J Pharmacol; 2021 Jan; 890():173650. PubMed ID: 33049303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylated glucagon-like peptide-1 displays preserved effects on insulin release in isolated pancreatic islets and improved biological activity in db/db mice.
    Lee S; Youn YS; Lee SH; Byun Y; Lee KC
    Diabetologia; 2006 Jul; 49(7):1608-11. PubMed ID: 16586064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, bioactivity and specificity of glucagon-like peptide-1 (7-37)/polymer conjugate to isolated rat islets.
    Kim S; Wan Kim S; Bae YH
    Biomaterials; 2005 Jun; 26(17):3597-606. PubMed ID: 15621250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like Peptide 1 Conjugated to Recombinant Human Serum Albumin Variants with Modified Neonatal Fc Receptor Binding Properties. Impact on Molecular Structure and Half-Life.
    Bukrinski JT; Sønderby P; Antunes F; Andersen B; Schmidt EGW; Peters GHJ; Harris P
    Biochemistry; 2017 Sep; 56(36):4860-4870. PubMed ID: 28799326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization, and pharmacokinetic studies of PEGylated glucagon-like peptide-1.
    Lee SH; Lee S; Youn YS; Na DH; Chae SY; Byun Y; Lee KC
    Bioconjug Chem; 2005; 16(2):377-82. PubMed ID: 15769092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide.
    Lau J; Bloch P; Schäffer L; Pettersson I; Spetzler J; Kofoed J; Madsen K; Knudsen LB; McGuire J; Steensgaard DB; Strauss HM; Gram DX; Knudsen SM; Nielsen FS; Thygesen P; Reedtz-Runge S; Kruse T
    J Med Chem; 2015 Sep; 58(18):7370-80. PubMed ID: 26308095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of GLP-1 and GIP on cAMP production, insulin secretion, and in vivo antidiabetic actions following substitution of Ala8/Ala2 with 2-aminobutyric acid.
    Green BD; Gault VA; Flatt PR; Harriott P; Greer B; O'Harte FP
    Arch Biochem Biophys; 2004 Aug; 428(2):136-43. PubMed ID: 15246869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring a novel long-acting glucagon-like peptide-1 receptor agonist built on the albumin-binding domain and XTEN scaffolds.
    Zhou Y; Li J; Gao G; Li Y; Zhang C
    Heliyon; 2024 Jan; 10(2):e24340. PubMed ID: 38293540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
    Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
    Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein.
    Glaesner W; Vick AM; Millican R; Ellis B; Tschang SH; Tian Y; Bokvist K; Brenner M; Koester A; Porksen N; Etgen G; Bumol T
    Diabetes Metab Res Rev; 2010 May; 26(4):287-96. PubMed ID: 20503261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of a cysteine to glucagon-like peptide-1 (GLP-1) conjugates GLP-1 to albumin in serum and prolongs GLP-1 action in vivo.
    Wu YL; Huang J; Xu J; Liu J; Feng Z; Wang Y; Lai Y; Wu ZR
    Regul Pept; 2010 Sep; 164(2-3):83-9. PubMed ID: 20570598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multifaceted potential of glucagon-like peptide-1 as a therapeutic agent.
    Lam NT; Kieffer TJ
    Minerva Endocrinol; 2002 Jun; 27(2):79-93. PubMed ID: 11961501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.
    Holst JJ
    Expert Opin Emerg Drugs; 2004 May; 9(1):155-66. PubMed ID: 15155141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
    Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
    Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrocarbon-Stitched Peptide Agonists of Glucagon-Like Peptide-1 Receptor.
    Bird GH; Fu A; Escudero S; Godes M; Opoku-Nsiah K; Wales TE; Cameron MD; Engen JR; Danial NN; Walensky LD
    ACS Chem Biol; 2020 Jun; 15(6):1340-1348. PubMed ID: 32348108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1.
    Green BD; Gault VA; Irwin N; Mooney MH; Bailey CJ; Harriott P; Greer B; Flatt PR; O'Harte FP
    Biol Chem; 2003 Dec; 384(12):1543-51. PubMed ID: 14719796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the GLP-1 receptor bound to a peptide agonist.
    Jazayeri A; Rappas M; Brown AJH; Kean J; Errey JC; Robertson NJ; Fiez-Vandal C; Andrews SP; Congreve M; Bortolato A; Mason JS; Baig AH; Teobald I; Doré AS; Weir M; Cooke RM; Marshall FH
    Nature; 2017 Jun; 546(7657):254-258. PubMed ID: 28562585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulation of pancreatic islets within nano-thin functional polyethylene glycol coatings for enhanced insulin secretion.
    Kizilel S; Scavone A; Liu X; Nothias JM; Ostrega D; Witkowski P; Millis M
    Tissue Eng Part A; 2010 Jul; 16(7):2217-28. PubMed ID: 20163204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-islet regulation of hormone secretion by glucagon-like peptide-1-(7--36) amide.
    Heller RS; Aponte GW
    Am J Physiol; 1995 Dec; 269(6 Pt 1):G852-60. PubMed ID: 8572216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.